Narayana Hrudayalaya Ltd. (NH) fundamentals
Narayana Hrudayalaya Ltd. is a listed company in Healthcare Services, part of the Healthcare sector, listed on the NSE as NH (ISIN INE410P01011). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Narayana Hrudayalaya Ltd. does
Narayana Hrudayalaya Limited is engaged in medical and healthcare services. The Company operates a network of multispecialty and super-specialty hospitals across multiple locations. Its operating segment is Medical and Healthcare Related Services. Its medical services include anesthesiology, audiology, breast oncology and oncoplastic surgery, clinical psychology, congenital adult heart disease, cardiac sciences, developmental and behavioral pediatrics, endocrinology and diabetology, gastrointestinal oncology, gynecologic oncology, hepatology and liver transplantation, interventional and endovascular radiology, medical gastroenterology, neuro rehabilitation, pediatric hematology oncology, speech and swallow rehabilitation, thoracic and vascular surgery, vascular and endovascular surgery, surgical gastroenterology, and surgical oncology, among others. It has a network of over 18 hospitals and three heart centers across India, along with an international presence in the Cayman Islands.
Valuation and market data
| Last close | ₹1869.20 |
|---|---|
| Market capitalisation | ₹38,188 crore |
| Enterprise value | ₹43,848 crore |
| P/E (TTM) | 47.12 |
| Price to book | 8.41 |
| Price to sales (TTM) | 2.64 |
| Book value per share | ₹222.20 |
| Dividend yield | 24.07% |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Listed since | Wed Jan 06 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹4,152 crore | ₹652 crore | ₹503 crore | 24.77 |
| Mar 2025 | ₹3,732 crore | ₹557 crore | ₹431 crore | 21.23 |
| Mar 2024 | ₹3,389 crore | ₹503 crore | ₹425 crore | 20.90 |
| Mar 2023 | ₹3,066 crore | ₹395 crore | ₹266 crore | 13.08 |
| Mar 2022 | ₹2,518 crore | ₹206 crore | ₹134 crore | 6.58 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 63.3% |
|---|---|
| Foreign institutions (FII) | 9.4% |
| Mutual funds | 7.3% |
| Other domestic institutions | 1.7% |
| Retail and others | 18.3% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.